Effectiveness Chronic Kidney Disease & Therapeutic Exercise
NCT ID: NCT03416140
Last Updated: 2020-03-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2018-02-15
2021-06-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Diabetic Kidney Disease: Influence of Exercise Therapy on Physical and Vascular Function.
NCT02112071
Exercise for Chronic Kidney Diseases
NCT04522115
Physical Exercise With Flow Restriction of the Forearm in Chronic Kidney Disease
NCT02619968
Physical Activity and Functioning in Home Dialysis Patients
NCT01602718
The Effects of Exercise in End-stage Renal Disease Patients Undergoing Hemodialysis
NCT02621918
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Therapeutic exercise
Therapeutic Exercise
30 minutes per day of therapeutic exercise
Control
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Therapeutic Exercise
30 minutes per day of therapeutic exercise
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidad de León
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
César Calvo Lobo
PhD, MSc, PT
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pierre Neyra Bohórquez, MD
Role: PRINCIPAL_INVESTIGATOR
Nephrology Unit, Galdakao Hospital, Spain
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pierre Neyra Bohórquez
Galdakao, Bizkaia, Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ERC_ULE_II
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.